drugset / Trial / NCT06930456

Comparison Between Intravenous Hydrocortisone and Ondansetron in Prevention of Post Spinal Anesthesia Hypotension

NCT06930456

Enrolling by invitation 120 enrolled Nada kamel Elgamal
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to assess and contrast the effectiveness of intravenous ondansetron and intravenous hydrocortisone in avoiding spinal anesthesia-induced hypotension.

Timeline

Start
2024-03-01
Primary completion
2025-03-01
Completion
2025-05-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrocortisone Other / unclassified 100 mg Intravenous
Comparator Ondansetron Other / unclassified 8 mg Intravenous

Indications